Adapt, innovate, and scale
At a turning point in clinical trial transformation, large biopharma companies rely on Medidata to adapt, scale, and realize their next breakthrough.
Why do 19 of the Top 20 large biopharma companies trust Medidata?
Large biopharma players are under pressure to adapt to disruptions, respond to patient centricity, detect risks earlier, and scale at an unprecedented pace to get therapies to market faster.
Medidata delivers the only life science technology platform that’s continually improved using 20+ years of ongoing digital leadership experience, data-driven approach, patient-centric and customer-centric focus, and a culture of innovation to help maximize the return on their technology investments, adapt to anything, and build for the future.
Unify the latest digital technologies, new data sources, and advanced analytics, to realize your next breakthrough and propel your growth.
Respond to changing needs or new opportunities. Adapt to new challenges, integrate new technologies, and meet patient expectations.
FOR THE FUTURE
Stay ahead of new disruptions, trends, and innovations. Invest in the technology that meets today’s opportunities and tomorrow’s transformation.
One technology platform to power people, processes, and progress.
Medidata helps you adapt, simplify, scale, and accelerate your clinical trials, from protocol design to study startup, conduct, close-out, and commercialization.
Our platform is built to enable you with cloud-based, modular, integrable, easily configurable capabilities, all powered by the latest patient, clinical and operational data, and AI solutions.
Adapt your patient-centric approach to leverage insights and optimize engagement at every stage of your trials.
Leverage cross-industry clinical trial data from 6 million patients and +23,000 trials to optimize your protocol feasibility, improve recruitment, and benchmark your study design to minimize patient burden and boost engagement and retention. Deliver powerful insights and the necessary evidence to increase the probability of success by connecting with real world data.
Use technology solutions designed from the patient perspective to meet patient preferences for data collection and participation, and seamlessly integrate into their everyday lives, improving the overall experience in clinical research operations.
To adapt, scale, and meet increasing requirements for virtual, decentralized, and hybrid trials, large biopharma needs a path to gain immediate advantage and leap into the next generation of clinical trials.
Within one scalable platform, Medidata enables remote patients to discover, evaluate and enroll in your study virtually.
Continuous remote monitoring of document review, targeted source data verification, and site activities enable risk remediation in real-time and with a fully auditable solution. Sites also gain efficiencies with the adoption of a single, standardized Imaging technology, delivering control and flexibility.
Supporting 330+ industry-sponsored COVID-19 studies in 70+ countries, Medidata teams up with large biopharma to pivot, adapt, and future proof their remote technologies to meet long-term compliance and future disruptions.
In the new reality, large biopharma organizations are required to launch, adapt, and pivot new and existing trials faster than ever. At the core of this new paradigm is data.
Optimize your trial design, operational feasibility, and trial performance according to data and predictive models benchmarking protocol, site and patient burden, and procedural cost. Leverage RWD to expand and better understand patient populations.
Accelerate enrollment through precise study, country, and site insights driven by cross-industry performance data and predictive models.
Improve study integrity, reduce risk, optimize efficiency and patient safety, unifying data capture and management in a single place for actionable insights and faster decision making.
Gain the ability to detect errors, trends, and anomalies to proactively perform root cause investigations and take corrective actions. Reduce trial risks with an RBQM approach to proactively enhance data quality.
Adapting for more complex, globally dispersed trials, and new technologies is compounded by unrelenting pressures to rein in cycle times and budgets. Unify your critical processes to improve and transform the clinical trial experience for patients, sponsors, CROs, and research sites.
Accelerate study startup, access data, connect work, and scale and manage trials faster, all in one place.
Use a single sign-on (SSO) to centralize your workflows, data, and operations in one system for a continuous work experience across your teams. Leverage systematic and seamless processes to eliminate duplicate data entry, multiple data migrations, or unnecessary reconciliation efforts.
Operate with a single view of all cross-application data and activities to maintain full control, improve inspection readiness and operational efficiencies.
“We’re gaining efficiencies from using Medidata’s software-as-a-service… we can keep it standard, design it for a therapeutic area, and reuse it over again for multiple studies.”
Associate Director, Clinical Data Management